Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 2 Interventional Accepts healthy volunteers

A Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-31 in Healthy Infants

ClinicalTrials.gov ID: NCT06720038

Public ClinicalTrials.gov record NCT06720038. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 4:24 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Randomized, Double-Blind, Active-Controlled, Dose-Finding Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-31 in Healthy Infants Given 4 Doses at 2, 4, 6, and 12-15 Months of Age Concomitantly With Routine Pediatric Vaccines

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The objective of the study is to evaluate the safety, tolerability, and immunogenicity of 4 injections of VAX-31 (at 4 dose levels) compared to PCV20 in infants at 2, 4, 6, and 12-15 months of age, in addition to receiving routine US concomitant vaccines. Stage 1 of the study will comprise 3 dose ascending cohorts. Stage 2 of the study will enroll approximately 352 subjects. Stage 3 of the study will enroll approximately 500 subjects.

Study identification

NCT ID
NCT06720038
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Vaxcyte, Inc.
Industry
Enrollment
900 participants

Conditions and interventions

Eligibility (public fields only)

Age range
42 Days to 89 Days
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 25, 2024 (Actual)
Primary completion
Dec 2027 (Estimated)
Completion
Dec 2027 (Estimated)
Last update posted
May 15, 2026

2024 – 2027

United States locations

U.S. sites
45
U.S. states
15
U.S. cities
35
Facility City State ZIP Site status
The Children's Clinic of Jonesboro, P.A Jonesboro Arkansas 72401 —
Matrix Clinical Research Gardena California 90237 —
Matrix Clinical Research Los Angeles California 90057 —
Orange County Research Institute Ontario California 91762 —
Center for Clinical Trials of San Gabriel West Covina California 91790 —
Children's Hospital of Colorado - Dept. of Infectious Disease Aurora Colorado 80045 —
SEC Clinical Research Pensacola Florida 32503 —
PAS Research Tampa Florida 33613 —
Clinical Research Prime, LLP Idaho Falls Idaho 83404 —
Clinical Research Prime - Rexburg Rexburg Idaho 83440 —
Kentucky Pediatrics/Adult Research Bardstown Kentucky 40004 —
ACC Pediatric Research Haughton Louisiana 71037 —
Complete Children's Health Lincoln Nebraska 68504 —
Complete Children's Health Lincoln Nebraska 68505 —
Be Well Clinical Studies Nebraska Lincoln Nebraska 68516 —
Complete Children's Health Lincoln Nebraska 68516 —
Complete Children's Health Lincoln Nebraska 68522 —
Ohio Pediatric Research Association Dayton Ohio 45414 —
Senders Pediatrics South Euclid Ohio 44121 —
Cyn3rgy Research Gresham Oregon 97030 —
UPMC Children's Community Pediatrics - Bass Wolfson, Cranberry Cranberry Township Pennsylvania 16066 —
Allegheny Health & Wellness Pavilion West Erie Pennsylvania 16506 —
UPMC Children's Community Pediatrics - Norwin N. Huntingdon Pennsylvania 15642 —
UPMC Children's Community Pediatrics South Hills-Jefferson Hills Pittsburgh Pennsylvania 15025 —
UPMC Children's Hospital of Pittsburgh - General Academic Pediatrics (GAP) Pittsburgh Pennsylvania 15213 —
UPMC Children's Community Pediatrics Bass Wolfson-Squirrel Hill Pittsburgh Pennsylvania 15217 —
UPMC Children's Community Pediatrics-Castle Shannon Pittsburgh Pennsylvania 15234 —
Tribe Clinical Research, LLC dba Neighbors Clinical Research Charleston South Carolina 29407 —
Tribe Clinical Research/Parkside Pediatrics Simpsonville South Carolina 29680 —
Proactive RGV LLC Brownsville Texas 78520 —
Javara Inc. /Texas Health Care, PLLC Dallas Texas 75001- —
Oak Cliff Research Company Dallas Texas 75287 —
Kool Kids Pediatrics (Dynamed) Houston Texas 77065 —
Sunrise Pediatrics Houston Texas 77077 —
Mercury Clinical Research - Pediatric Associates Houston Texas 77087 —
University of Texas Medical Branch - Sealy Institute for Vaccine Sciences, Clinical Trials Program League City Texas 77573 —
Pediatric Center/Neutra Life Sciences Richmond Texas 77469 —
AMR - Layton Layton Utah 84041 —
AMR - Cottonwood Murray Utah 84107 —
AMR - Roy Roy Utah 84067 —
AMR South Jordan South Jordan Utah 84095 —
AMR - Syracuse Syracuse Utah 84075 —
Pediatric Research of Charlottesville, LLC Charlottesville Virginia 22902 —
Pediatric Research of Charlottesville, LLC Gordonsville Virginia 22942 —
Clinical Research Partners, LLC. Richmond Virginia 23226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06720038, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 15, 2026 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06720038 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →